Jul 7, 2026 07:18AM
Jun 26, 2026 10:02AM
Jun 26, 2026 10:02AM
Jun 26, 2026 09:05AM
Jun 26, 2026 09:05AM
May 13, 2026 04:15AM
May 12, 2026 04:05PM Capricor Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 8, 2026 07:15AM
Apr 22, 2026 09:02AM
Apr 22, 2026 09:00AM
Mar 13, 2026 07:30AM
Mar 12, 2026 04:01PM
Mar 12, 2026 09:02AM
Mar 12, 2026 09:00AM Capricor Therapeutics Announces Late-Breaking HOPE-3 Data at the 2026 MDA Conference Demonstrating Significant Functional Benefits of Deramiocel for Duchenne Muscular Dystrophy
Mar 10, 2026 10:37AM
Mar 10, 2026 10:05AM
Mar 10, 2026 09:25AM
Mar 10, 2026 09:25AM
Mar 9, 2026 07:46AM
Feb 24, 2026 09:00AM
Jan 29, 2026 06:21AM Oppenheimer Reiterates Outperform Rating on Capricor Therapeutics (CAPR)
Jan 20, 2026 09:15AM
Jan 20, 2026 09:15AM
Jan 16, 2026 07:11AM
Dec 22, 2025 07:06AM
Dec 21, 2025 04:00AM
Dec 17, 2025 06:59AM
Dec 16, 2025 04:05PM Capricor and PPMD to host webinar on phase 3 trial results
Dec 16, 2025 04:05PM
Dec 10, 2025 07:42AM
Dec 8, 2025 07:09AM
Dec 3, 2025 02:59PM
Dec 3, 2025 07:20AM
Dec 3, 2025 07:20AM
Dec 3, 2025 07:20AM Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
Nov 10, 2025 04:01PM
Nov 3, 2025 09:15AM
Nov 3, 2025 09:15AM
Sep 25, 2025 07:15AM
Sep 25, 2025 07:15AM
Sep 18, 2025 05:08AM
Sep 12, 2025 06:46AM H.C. Wainwright Reiterates Buy Rating on Capricor Therapeutics (CAPR)
Sep 9, 2025 09:23AM
Sep 9, 2025 09:20AM
Aug 19, 2025 06:40AM
Aug 18, 2025 09:00AM
Aug 18, 2025 09:00AM
Aug 11, 2025 04:05PM
Aug 8, 2025 08:30AM Capricor schedules FDA meeting on Deramiocel regulatory path
Aug 8, 2025 08:30AM

325,591 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All